Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substrate intervention

Journal of Molecular and Cellular Cardiology

Volumn 44, Issue 2, 2008, Pages 270-280

  Huggins, C E ^a   Domenighetti, A A ^a   Ritchie, M E ^b   Khalil, N ^a   Favaloro, J M ^a   Proietto, J ^a   Smyth, G K ^b   Pepe, S ^c   Delbridge, L M D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Gene expression profiling; GLUT4 transporter; Glycolysis; Hypertrophy; Insulin resistance; Metabolic remodelling; Myocardial metabolism

Indexed keywords

GLUCOSE TRANSPORTER 4;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART CONTRACTION; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AGING; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DOWN-REGULATION; ENERGY METABOLISM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HEART RATE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIUM; ORGAN SIZE; PYRUVIC ACID; SUBSTRATE SPECIFICITY; TIME FACTORS; UP-REGULATION;

MURINAE;

EID: 39149116657     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.11.020     Document Type: Article

References (34)

1. 2+-ATPase function is warranted for immature pressure overload hypertrophied myocardium. Jpn Circ J 65 (2001) 1064-1070
2. 2+ release by glycolysis in cat atrial myocytes. J Physiol 564 (2005) 697-714
3. Sowers J.R., Epstein M., and Frohlich E.D. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37 (2001) 1053-1059
4. Lehman J., and Kelly D.P. Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev 7 (2002) 175-185
5. Paternostro G., Pagano D., Gnecchi-Ruscone T., Bonser R.S., and Camici P.G. Insulin resistance in patients with cardiac hypertrophy. Cardiovasc Res 42 (1999) 246-253
6. Razeghi P., Young M.E., Cockrill T.C., Frazier O.H., and Taegtmeyer H. Downregulation of myocardial myocyte enhancer factor 2C and myocyte enhancer factor 2C-regulated gene expression in diabetic patients with nonischemic heart failure. Circulation 106 (2002) 407-411
7. Kaczmarczyk S.J., Andrikopouloulos S., Favaloro J., Domenighetti A.A., Huggins C.E., Dunn A., et al. Threshold effects of GLUT4 deficiency on cardiac glucose uptake and development of hypertrophy. J Mol Endocrinol 31 (2003) 449-459
8. Ritchie R.H., Quinn J.M., Cao A.H., Drummond G.R., Kaye D.M., Favaloro J.M., et al. The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 42 (2007) 1119-1128
9. Katz E.B., Stenbit A.E., Hatton K., DePinho R., and Charron M.J. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377 (1995) 151-155
10. Paternostro G., Clarke K., Heath J., Seymour A.-M.L., and Radda G.K. Decreased GLUT-4 mRNA and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res 30 (1995) 205-211
11. Abel E.D., Kaulbach H.C., Tian R., Hopkins J.C.A., Duffy J., Doetchman T., et al. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from heart. J Clin Invest 104 (1999) 1703-1714
12. Ritchie R.H., and Delbridge L.M.D. Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect?. Clin Exp Pharmacol Physiol 33 (2006) 171-178
13. Huggins C.E., Domenighetti A.A., Pedrazzini T., Pepe S., and Delbridge L.M.D. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice. J Renin Angiotensin Aldosterone Syst 4 (2003) 186-190
14. Headrick J.P., Peart J., Hack B., Flood A., and Matherne G.P. Functional properties and responses to ischaemia-reperfusion in Langendorff perfused mouse heart. Exp Physiol 86 (2001) 703-716
15. Kargul G.J., Dudekula D.B., Qian Y., Lim M.K., Jaradat S.A., and Tanaka T.S. Verification and initial annotation of the NIA mouse 15K cDNA clone set. Nature Genetics 28 (2001) 17-18
16. Smyth G.K., and Speed T. Normalization of cDNA microarray data. Methods 31 (2003) 265-273
17. Ritchie M.E., Diyagama D., Neilson J., van Laar R., Dobrovic A., Holloway A., and Smyth G.K. Empirical array quality weights for microarray data. BMC Bioinformatics 7 (2006) 261
18. Smyth G.K., Michaud J., and Scott H. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21 (2005) 2067-2075
19. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3 (2004) (Article 3)
20. Dennis Jr. G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 (2003) R60
21. Sutherland F.J., Shattock M.J., Baker K.E., and Hearse D.J. Mouse isolated perfused heart: characteristics and cautions. Clin Exp Pharmacol Physiol 30 (2003) 867-878
22. Liao R., Jain M., Cui L., D'Agostino J., Aiello F., Luptak I., et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106 (2002) 2125-2131
23. 13C mass isotopomer study of anaplerotic pyruvate carboxylation in perfused rat heart. J Biol Chem 272 (1997) 26125-26131
24. Sorokina N., O'Donnell J.M., McKinney R.D., Pound K.M., Woldegiorgis G., LaNoue K.F., et al. Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts. Circulation 115 (2007) 2033-2041
25. 2+ release in rats via mitochondria-dependent and-independent mechanisms. J Physiol 550 (2003) 765-783
26. Mallet R.T., and Sun J. Mitochondrial metabolism of pyruvate is required for its enhancement of cardiac function and energetics. Cardiovasc Res 42 (1999) 149-161
27. Hermann H.-P., Pieske B., Schwarzmuller E., Keul J., Just H., and Hasenfuss G. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. The Lancet 353 (1999) 1321-1323
28. 2+ cycling in isolated failing human myocardium. Circulation 105 (2002) 194-199
29. 2+ transients and contractile responses of diabetic rat cardiomyocytes. Circ Res 46 (2000) 450-462
30. Dutta K., Podolin D.A., Davidson M.B., and Davidoff A.J. Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance. Diabetes 50 (2001) 1186-1192
31. Lo A.S.-Y., Liew C.-T., Ngai S.-M., Tsui S.K.-W., Fung K.-P., Lee C.-Y., and Waye M.M.-Y. Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1). J Cell Biochem 94 (2005) 763-773
32. Gibala M.J., Young M.E., and Taegtmeyer H. Anaplerosis of the citric acid cycle: role in energy metabolism of heart and skeletal muscle. Acta Physiol Scand 168 (2000) 657-665
33. Abel E.D. Glucose for the aging heart?. Circulation 116 (2007) 884-887
34. Binas B., Danneberg H., McWhir J., Mullins L., and Clark J. Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization. FASEB J 13 (1999) 805-812